Pulse Biosciences, Inc.
|Company Name||Pulse Biosciences, Inc.|
On September 11, 2017, Pulse announced that it withdrew its application to the FDA for 510(k) clearance of its PulseTx System. The Company further stated that the withdrawal was the result of “the FDA’s appropriate request for additional data that could not be provided within the Agency’s 90-day review period that would have otherwise ended on September 10, 2017.”
On this news, shares of Pulse fell more than 14% during intraday trading on September 11, 2017, thereby damaging investors.
Submit Your Information
If you suffered a loss on your Pulse Biosciences, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.